Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced it has begun the process required to establish an expanded access program (EAP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE